imipenem, anhydrous has been researched along with Infection in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
| Gonçalves-Pereira, J; Póvoa, P | 1 |
| Chen, C; Fang, JP; Huang, SL; Li, Y; Zhou, DH | 1 |
| Astorri, AL; Bondì, M; Maglione, A; Mancuso Bondì, S; Oliva, C; Paparella, P; Zullo, MA | 1 |
| Freifeld, AG | 1 |
| Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
| Bjornson, HS; Bohnen, JM; Coulter, HO; Dellinger, EP; Echols, RM; Haverstock, DC; Hill, CS; Reinhart, HH; Rotstein, OD; Simms, HH; Solomkin, JS; Vogel, SB | 1 |
| Arranz, R; Cámara, R; del Rey, MC; Fernández-Rañada, JM; Figuera, A; Hernández, L; Jiménez, ML; López-Lorenzo, JL; Peñarrubia, MJ; Tomás, JF | 1 |
| Albinger, C; Olesch, HV; Schaumann, R; Shah, PM; Stille, W | 1 |
| Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY | 1 |
| de Lissovoy, G; Elixhauser, A; Luce, BR; Mowery, P; Reblando, J; Solomkin, J; Weschler, J | 1 |
| Attanasio, E; Basoli, A; Caprino, L; Carunchio, G; Russo, P | 1 |
| Kühl, J; Lehrnbecher, T; Stanescu, A | 1 |
| Shevchuk, YM | 1 |
| Pizzo, PA; Rubin, M | 1 |
2 review(s) available for imipenem, anhydrous and Infection
| Article | Year |
|---|---|
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Infections; Meropenem; Piperacillin; Thienamycins | 2011 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
6 trial(s) available for imipenem, anhydrous and Infection
| Article | Year |
|---|---|
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Topics: Abdomen; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Infections; Infusions, Intravenous; Metronidazole; Middle Aged; Treatment Outcome | 1996 |
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Thienamycins; Vancomycin | 1996 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome | 1997 |
Cost-effectiveness study of imipenem/cilastatin versus meropenem in intra-abdominal infections.
Topics: APACHE; Cilastatin; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Female; Health Care Costs; Humans; Imipenem; Infections; Male; Meropenem; Middle Aged; Peritoneal Diseases; Protease Inhibitors; Thienamycins | 2000 |
Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
Topics: Adolescent; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Imipenem; Infant; Infections; Injections, Intravenous; Male; Neoplasms; Neutropenia; Retrospective Studies; Teicoplanin; Time Factors | 2002 |
8 other study(ies) available for imipenem, anhydrous and Infection
| Article | Year |
|---|---|
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
[Clinical analysis of 29 children with early infectious complications following hematopoietic stem cells transplantation].
Topics: Adolescent; Antibiotic Prophylaxis; Child; Child, Preschool; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Incidence; Infections; Leukemia; Male; Retrospective Studies; Time Factors | 2003 |
[Treatment in the event of antibiotic prophylaxis failure in gynecologic surgery. A retrospective study of 20 cases].
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Imipenem; Infections; Middle Aged; Postoperative Complications; Premedication; Retrospective Studies; Surgical Wound Infection | 1994 |
Experience with imipenem in internal medicine--a postmarketing surveillance study.
Topics: Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Germany; Humans; Imipenem; Infections; Male; Middle Aged; Product Surveillance, Postmarketing | 1997 |
Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intra-abdominal infection.
Topics: Abdomen; Cilastatin; Clindamycin; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Infections; Regression Analysis; Retrospective Studies; Tobramycin | 1993 |
Antimicrobial agents in neutropenic patients with unexplained fever.
Topics: Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fever of Unknown Origin; Humans; Imipenem; Infections; Neutropenia | 1991 |
Monotherapy for empirical management of febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; Humans; Imipenem; Infections; Neutropenia; Quinolones | 1990 |
Imipenem/cilastatin.
Topics: Chemical Phenomena; Chemistry; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Humans; Imipenem; Infections; Thienamycins | 1988 |